Skip to main content
. 2021 Nov 15;145(3):184–193. doi: 10.1161/CIRCULATIONAHA.121.057812

Figure 1.

Figure 1.

Effect of empagliflozin on outcomes by baseline KCCQ tertiles. CSS indicates Clinical Summary Score; KCCQ, Kansas City Cardiomyopathy Questionnaire; OSS, Overall Summary Score; and TSS, total symptom score. *P value from trend test assuming ordering of the KCCQ tertiles